Dr Reddy's director files initial share report

DR REDDYS LABORATORIES LTD director Sanjiv Soshil Mehta has filed an initial Form 3, which is a baseline statement of his beneficial ownership in the company’s securities.

Accepted by SEC EDGAR 03/27/2026 - 08:39 AM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

DR REDDYS LABORATORIES LTD director Sanjiv Soshil Mehta has filed an initial Form 3, which is a baseline statement of his beneficial ownership in the company’s securities. The filing does not report any stock purchases, sales, option exercises, or other transactions.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the DR REDDYS LABORATORIES LTD (RDY) Form 3 filing report for Sanjiv Soshil Mehta?

The Form 3 shows that director Sanjiv Soshil Mehta has filed his initial statement of beneficial ownership in DR REDDYS LABORATORIES LTD. It is a baseline disclosure and reports no stock transactions or option exercises.

Does the RDY Form 3 for Sanjiv Soshil Mehta show any stock purchases or sales?

No, the Form 3 for Sanjiv Soshil Mehta reports no stock purchases or sales. It simply establishes his initial ownership status as a director, with zero buy, sell, or exercise transactions listed in the summary data.

What is the role of Sanjiv Soshil Mehta in DR REDDYS LABORATORIES LTD (RDY)?

According to the Form 3, Sanjiv Soshil Mehta is a director of DR REDDYS LABORATORIES LTD. He is not identified as an officer or ten-percent owner in this filing, and no officer title is provided in the disclosure.

Does the RDY Form 3 include any derivative securities or option positions for Sanjiv Soshil Mehta?

The filing’s derivative section is empty, indicating no reported derivative securities such as stock options or warrants for Sanjiv Soshil Mehta. The derivative transaction count and exercise-related fields are all shown as zero in the summary.

Are there any gifts, tax withholdings, or restructuring transactions in the RDY Form 3 for Sanjiv Soshil Mehta?

No. The transaction summary shows zero gifts, tax withholdings, and restructuring entries for Sanjiv Soshil Mehta. All related counts and share amounts are listed as zero, confirming there are no such movements reported in this initial filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

MEHTA SANJIV SOSHIL

(Last) (First) (Middle)

E- 5703 WORLD CREST,

LODHA WORLD TOWERS, LOWER PAREL,

(Street)

MUMBAI MAHARASHTRA 400013

(City) (State) (Zip)

INDIA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
12/18/2025

3. Issuer Name and Ticker or Trading Symbol
DR REDDYS LABORATORIES LTD [ RDY ]

3a. Foreign Trading Symbol
[DRREDDY&500124]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ SANJIV SOSHIL MEHTA	03/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)